Log in to search using one of your social media accounts:

 

British Thoracic Society Guideline for Oxygen Use in Adults British Thoracic Society Guideline for Oxygen Use in Adults

These guidelines provide updated recommendations for the use of oxygen in adults in healthcare and emergency settings.BMJ Open Respiratory Research
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Related Links:

One additional high - risk patient immunized for every 29 SMSs sent, costing $ 3.48
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Allergy, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
While many studies have suggested this could be the case, this research by Boston Children's Hospital offers the clearest evidence that breast milk can prevent allergies.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Condition:   Loss of Facial Adipose Tissue Intervention:   Other: Study Photography + Personal&Medical History Collection Sponsors:   McDaniel Institute of Anti-Aging Research;   Allergan;   Merz Aesthetics Inc.;   ThermiGen, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: The Laryngoscope - Category: ENT & OMF Authors: Tags: Allergy/Rhinology Source Type: research
First and only epinephrine auto-injector (EAI) approved with a needle length and dose specifically designed for infants and children weighing 16.5 to 33 pounds (7.5 to 15 kilograms) Anaphylaxis and food allergies increasing in children; previously no EA... Biopharmaceuticals, Devices, Drug Delivery, FDA Kaléo, AUVI-Q, Epinephrine, auto-injector
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
The FDA has approved Kaleo‘s Auvi-Q epinephrine auto-injector designed to treat life-threatening allergic reactions in infants and small children, according to the privately-held biopharma company. The device, which Kaleo touts as the first of its kind, was given priority review by the FDA. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves Kaleo’s allergy auto-injector designed for infants appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Pediatrics Pharmaceuticals Regulatory/Compliance Respiratory Kaleo Inc Source Type: news
Pediatric Allergy, Immunology, and Pulmonology , Vol. 0, No. 0.
Source: Pediatric, Allergy, Immunology, and Pulmonology - Category: Respiratory Medicine Authors: Source Type: research
ConclusionThe GA2LEN chamber provides a  novel mobile exposure chamber technology for research and clinical trials allowing a fast, affordable, and standardized multicenter approach.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research
Summary Antibiotics have been hailed by many as “miracle drugs” that have been effectively treating infectious diseases for over a century, leading to a marked reduction in morbidity and mortality. However, with the increasing use of antibiotics, we are now faced not only with the increasing threat of antibiotic resistance, but also with a rising concern about potential long‐term effects of antibiotics on human health, including the development of obesity. The obesity pandemic continues to increase, a problem that affects both adults and children alike. Disruptions to the gut microbiome have been linked to a ...
Source: Clinical Endocrinology - Category: Endocrinology Authors: Tags: UNSOLICITED REVIEW Source Type: research
Treatment of gonorrhoea is a challenge worldwide because of emergence of resistance in N. gonorrhoeae to all therapeutic antimicrobials available and novel antimicrobials are imperative. The newer‐generation fluoroquinolone sitafloxacin, mostly used for respiratory tract infections in Japan, can have a high in vitro activity against gonococci. However, only a limited number of recent antimicrobial‐resistant isolates from Japan have been examined. We investigated the sitafloxacin activity against a global gonococcal panel (250 isolates cultured in 1991–2013), including multidrug‐resistant geographically, tempora...
Source: APMIS - Category: Research Authors: Tags: Original Article Source Type: research
More News: Allergy | Allergy & Immunology | Emergency Medicine | Respiratory Medicine | UK Health